.Adjustments to Financial Statements
Difficulty: Advanced
Adjustments to Current Assets
Abbott Laboratories, adjusted current assets
USD $ in millions
| Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | ||
|---|---|---|---|---|---|---|
| As Reported | ||||||
| | Current assets | |||||
| Adjustments | ||||||
| | Add: Allowances for doubtful accounts and product returns | |||||
| | Less: Deferred income taxes1 | |||||
| After Adjustment | ||||||
| | Adjusted current assets | |||||
Source: Based on data from Abbott Laboratories Annual Reports
1 Deferred income taxes. See Details »
Adjustments to Total Assets
Abbott Laboratories, adjusted total assets
USD $ in millions
| Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | ||
|---|---|---|---|---|---|---|
| As Reported | ||||||
| | Total assets | |||||
| Adjustments | ||||||
| | Add: Operating leased assets1 | |||||
| | Add: Allowances for doubtful accounts and product returns | |||||
| | Less: Deferred income taxes2 | |||||
| After Adjustment | ||||||
| | Adjusted total assets | |||||
Source: Based on data from Abbott Laboratories Annual Reports
1 Operating leased assets. See Details »
2 Deferred income taxes. See Details »
Adjustments to Total Liabilities
Abbott Laboratories, adjusted total liabilities
USD $ in millions
| Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | ||
|---|---|---|---|---|---|---|
| As Reported | ||||||
| | Total liabilities | |||||
| Adjustments | ||||||
| | Add: Operating lease obligations1 | |||||
| | Less: Deferred income taxes2 | |||||
| | Less: Restructuring Plans, accrued balance | |||||
| After Adjustment | ||||||
| | Adjusted total liabilities | |||||
Source: Based on data from Abbott Laboratories Annual Reports
1 Operating lease obligations. See Details »
2 Deferred income taxes. See Details »
Adjustments to Stockholders' Equity
Abbott Laboratories, adjusted total shareholders' investment
USD $ in millions
| Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | ||
|---|---|---|---|---|---|---|
| As Reported | ||||||
| | Total Abbott shareholders' investment | |||||
| Adjustments | ||||||
| | Less: Net deferred tax assets (liabilities)1 | |||||
| | Add: Allowances for doubtful accounts and product returns | |||||
| | Add: Restructuring Plans, accrued balance | |||||
| | Add: Noncontrolling interests in subsidiaries | |||||
| After Adjustment | ||||||
| | Adjusted total shareholders' investment | |||||
Source: Based on data from Abbott Laboratories Annual Reports
1 Net deferred tax assets (liabilities). See Details »
Adjustments to Capitalization Table
Abbott Laboratories, adjusted capitalization table
USD $ in millions
| Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | ||
|---|---|---|---|---|---|---|
| As Reported | ||||||
| | Short-term borrowings | |||||
| | Current portion of long-term debt | |||||
| | Long-term debt, excluding current portion | |||||
| | Total reported debt | |||||
| | Total Abbott shareholders' investment | |||||
| | Total reported capital | |||||
| Adjustments to Debt | ||||||
| | Add: Operating lease obligations1 | |||||
| | Adjusted total debt | |||||
| Adjustments to Equity | ||||||
| | Less: Net deferred tax assets (liabilities)2 | |||||
| | Add: Allowances for doubtful accounts and product returns | |||||
| | Add: Restructuring Plans, accrued balance | |||||
| | Add: Noncontrolling interests in subsidiaries | |||||
| | Adjusted total shareholders' investment | |||||
| After Adjustment | ||||||
| | Adjusted total capital | |||||
Source: Based on data from Abbott Laboratories Annual Reports
1 Operating lease obligations. See Details »
2 Net deferred tax assets (liabilities). See Details »
Adjustments to Reported Income
Abbott Laboratories, adjusted comprehensive income (loss)
USD $ in millions
| 12 months ended | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | |
|---|---|---|---|---|---|---|
| As Reported | ||||||
| | Net earnings | |||||
| Adjustments | ||||||
| | Add: Deferred income tax expense (benefit)1 | |||||
| | Add: Increase (decrease) in allowances for doubtful accounts and product returns | |||||
| | Add: Increase (decrease) in restructuring Plans, accrued balance | |||||
| | Less: Net earnings from discontinued operations, net of taxes | |||||
| | Add: Other comprehensive income (loss) | |||||
| After Adjustment | ||||||
| | Adjusted comprehensive income (loss) | |||||
Source: Based on data from Abbott Laboratories Annual Reports
1 Deferred income tax expense (benefit). See Details »
